Survival Outcomes among Human Epidermal Growth Factor Receptor 2- (HER2-) Positive Breast Cancer Patients at Kenyatta National Hospital

Table 3

Treatment regimen administered to the HER2-positive breast cancer patients.

Variable	Frequency	Percent
Treatment regimen for early-stage disease
Radiotherapy	8	25
Chemotherapy	11	34.4
Surgery	10	31.3
Trastuzumab	3	9.3
Treatment regimen for the incurable disease
Radiotherapy	6	33.3
Chemotherapy	11	61.1
Trastuzumab	1	5.6